Betts v. Option Care Enterprises, Inc.

CourtDistrict Court, N.D. Illinois
DecidedJanuary 15, 2019
Docket1:18-cv-04023
StatusUnknown

This text of Betts v. Option Care Enterprises, Inc. (Betts v. Option Care Enterprises, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Betts v. Option Care Enterprises, Inc., (N.D. Ill. 2019).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

LISA BETTS,

Plaintiff, Case No. 18-cv-4023

v.

OPTION CARE ENTERPRISES, INC., et al. Judge John Robert Blakey

Defendant.

MEMORANDUM OPINION AND ORDER

In 2004, Plaintiff Lisa Betts, a doctor of pharmacy and 25-year veteran of the medical field, co-founded a company specializing in immune globulin therapy. The company achieved great success. In 2009, she sold that company to Walgreen Company (Walgreens), which then in 2015 sold its majority interest to Madison Dearborn Partners (MDP). Throughout these ownership changes, Plaintiff remained at the company and continued to grow the product lines she oversaw. Then, on April 18, 2017, the company she co-founded more than a decade earlier, abruptly fired her. Plaintiff now sues that company, Option Care, as well as Walgreens and MDP, alleging that Defendants discriminated against her because of her gender and wrongfully terminated her employment, in violation of various federal and state laws. Defendants move to dismiss [38] [41] [44]. For the reasons explained below, this Court denies Defendants’ motions. I. The Complaint’s Allegations1 A. Plaintiff’s Background Plaintiff, who has a doctorate degree in pharmacy, has spent over 25 years

working in the medical field. [35] ¶ 9. In 2004, Plaintiff co-founded one of Option Care’s predecessor companies, a home infusion company specializing in immune globulin (IG) therapy. Id. ¶¶ 9–10. That company achieved financial success, generating $30 million in annual revenue within five years. Id. ¶ 10. In 2009, Walgreens purchased Plaintiff’s company and requested Plaintiff and her business partner stay on for at least two years to oversee its continued success

(the two-year retention period). Id. ¶ 11. Walgreens operated the company under the name “Walgreens Infusion Services.” Id. During the two-year retention period, Plaintiff served as the General Manager for the company’s Lombard facility; in that role, she oversaw operations and helped grow the IG program into the largest revenue-generating infusible therapy for the company. Id. ¶ 13. Following the two-year retention period, Plaintiff became the National Director of IG, and in that role, oversaw all operations and sales for IG therapy. Id.

¶ 14. The company’s revenues grew from $64 million each year to $420 million each year. Id. ¶ 15. Plaintiff also grew the two product lines she oversaw and created and designed a data outcome IG software program, which she published in the Journal of Neurology. Id. ¶ 16.

1 This Court takes these alleged facts from Plaintiff’s amended complaint [35]. In 2015, Walgreens sold its majority ownership interest in the company to MDP (a private equity firm), retaining a minority interest. Id. ¶¶ 7, 12. After this sale, the company’s new name became “Option Care.” Id. ¶ 12.

B. The Alleged Discriminatory Conduct Plaintiff asserts that, despite her accomplishments and contributions to the company, Defendants discriminated against her because of her gender. Id. ¶ 19. Plaintiff alleges that Defendants’ discrimination included: ● In September 2016, Option Care replaced Plaintiff with a male employee, Steven Hess, to fill a position Plaintiff held since 2009.

Option Care paid Hess, who was less qualified than Plaintiff and had no experience in IG or infusion drugs, more than it paid Plaintiff for the same work. Upon hiring him, Option Care immediately gave Hess the more prestigious title of “Vice President,” whereas Plaintiff held the subordinate title of “Director.” Id. ¶¶ 21–23. ● Plaintiff interviewed Hess when Option Care considered hiring him. During the interview, Hess repeatedly disparaged another female

employee. When Plaintiff voiced concern to her direct supervisor, Chief Operations Officer John Rademacher, he ignored her concerns. Id. ¶ 24. ● Hess engaged in gross misconduct, including sexual harassment, without repercussion. For instance, Hess told Plaintiff that he wanted to “spoon” with her. On another occasion, in the presence of another employee, Hess said that he and Plaintiff were “going to make love.” Another employee witnessed the latter comment and reported it to her supervisor. Id. ¶ 24. ● Hess undermined Plaintiff’s authority and standing, ignoring Plaintiff’s

calls, text messages and emails. He did not treat male colleagues in a similar manner. Id. ¶ 25. ● Once Option Care removed Plaintiff from her position that it ultimately gave Hess, Option Care held her to unreasonable performance expectations. Specifically, Option Care told Plaintiff it expected her to increase revenues by over 15% within the next calendar year, under

threat of termination, even though no one had ever attained that level of growth within one fiscal year. Further, Option Care made several decisions in 2017 that interfered with Plaintiff’s efforts to increase revenues, including, for example, taking actions that decreased the company’s market share. Id. ¶¶ 27–30. ● Option Care criticized Plaintiff on a weekly basis when revenue did not grow at the high rate it set; when Plaintiff tried to discuss the issues

with Rademacher, he was dismissive and disinterested in addressing them. Plaintiff also unsuccessfully attempted to discuss the issues with CFO Mike Shapiro, who told her he had no time to speak with her, and CEO Paul Mastrapa, who told Plaintiff she was being defensive. Id. ¶ 32. ● Further, while holding Plaintiff to high performance expectations not similarly placed upon men, Option Care took away Plaintiff’s administrative support staff. Option Care also took away Plaintiff’s

office in Lombard and gave it to Hess, forcing Plaintiff to work in Bannockburn, even though it was a 1–2 hour drive from her home. In contrast, Hess had the option of working at either location on a day-to- day basis. Id. ¶ 33. ● In fall 2016, Plaintiff asked Ted Raad, Option Care’s Chief Commercial Officer, for a raise, but Raad asked her why she needed more money

since she had done well after selling her company to Option Care. Similarly, in October 2015, Mastrapa commented on Plaintiff’s continuing to work when she did not need the money. These executives did not direct such comments to male employees who chose to work but did not need to do so. Id. ¶¶ 35–37. ● Between 2009 and 2016, Plaintiff did not receive a single meaningful pay raise. Upon Plaintiff’s information and belief, similarly situated

men received better pay and meaningful raises over the years. Further, Plaintiff did not receive an opportunity to invest in the company when Walgreens sold its majority interest to MDP in 2015, even though lower- level employees and Plaintiff’s former partner—a male—received such opportunities. Id. ¶¶ 38–39. In addition to Plaintiff, Hess directed discriminatory conduct toward other employees. For instance, Hess made sexually explicit comments to at least one other female employee. Id. ¶ 24. He asked that female employee about her boyfriend and

then, while making an obscene gesture with his hand and fingers, said, “Oh, you have a fuck buddy.” Id. When the female employee expressed offense, Hess said, “We’re at an after-hours event so you can’t report me, plus I’m good friends with [the Senior Vice President of] Human Resources.” Id. Further, at a business meeting which Plaintiff attended, Hess mocked an Asian employee for her accent; that Asian employee teared up and told Hess that she

did not think Human Resources would like what he just did to her. Id. Hess responded by telling the Asian employee that he was friends with the Senior Vice President of Human Resources. Id. And, at yet another business meeting, Hess mimicked a disabled person by twitching his body and making offensive facial expressions. Id. C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
National Railroad Passenger Corporation v. Morgan
536 U.S. 101 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Lynda Fallon v. State of Illinois
882 F.2d 1206 (Seventh Circuit, 1989)
Anne Dey v. Colt Construction & Development Company
28 F.3d 1446 (Seventh Circuit, 1994)
Judith Hilt-Dyson v. City of Chicago
282 F.3d 456 (Seventh Circuit, 2002)
William L. Lucas v. Chicago Transit Authority
367 F.3d 714 (Seventh Circuit, 2004)
Bernard Pruitt v. City of Chicago, Illinois
472 F.3d 925 (Seventh Circuit, 2006)
Julie Boumehdi v. Plastag Holdings, LLC
489 F.3d 781 (Seventh Circuit, 2007)
Jajeh v. County of Cook
678 F.3d 560 (Seventh Circuit, 2012)
Kimberly Passananti v. Cook County
689 F.3d 655 (Seventh Circuit, 2012)
Tamayo v. Blagojevich
526 F.3d 1074 (Seventh Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Betts v. Option Care Enterprises, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/betts-v-option-care-enterprises-inc-ilnd-2019.